Molecular vibrations, when paired with near-infrared (NIR) light, have opened a new chapter in cancer treatment. Instead of ...

Outpatient laboratory test results were notable for a glucose level of 519 mg per deciliter (29 mmol per liter; reference range, 70 to 100 mg per deciliter [3.9 to 5.6 mmol per liter]).

The global high flow oxygen therapy devices market is anticipated to witness moderate growth, rising from USD 1.3 billion in 2025 to USD 1.6 billion by 2035 at a CAGR of 2.1% over the forecast period.

More information: Daniel S. Martin et al, Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients, JAMA (2025). DOI: 10.1001/jama.2025.9663 ...

To ensure that Medicare Part B covers your oxygen therapy, you must receive a diagnosis of a qualifying medical condition and have a physician’s order for oxygen therapy. You must undergo ...

Hyperbaric oxygen therapy helped an Army veteran and volunteer firefighter suffering from side-effects of chemotherapy and ...

An individual with Original Medicare must pay an annual Part B deductible, which is $257 in 2025. They will also have to pay 20% of the Medicare-approved amount for HBOT or home oxygen therapy ...

In this study of an AAV9-based gene therapy in four patients with infantile-onset Pompe’s disease, one patient died and one had pneumonia that led to the temporary administration of oxygen ...

Some COVID-19 patients have experienced silent hypoxia, a condition causing low oxygen levels (without obvious symptoms). This condition can be fatal.

Africa Hyperbaric Oxygen Therapy (HBOT) Devices Market Outlook 2035 The Africa hyperbaric oxygen therapy (HBOT) devices industry was valued at US$ 50.83 Mn in 2024 It is projected to grow at a CAGR of ...